secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001193125-26-174531
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology reclassifies director Steven D. Harr from Class I to Class III to balance board classes
--------------------------------------------------------------------------------

- Director Steven D. Harr resigned as Class I director and was reappointed as Class III director effective April 22, 2026.
- Change made solely to achieve equal board-class balance per certificate of incorporation.
- Board now has three directors in each of Class I, II, and III.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526174531/0001193125-26-174531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526174531/sana-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-174531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer